Loading...

Home
Stock
SER

SER News & Events

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Stock Price Prediction Technical Valuation Financials Earnings Should I Buy News & Events

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

SER News

Serina Therapeutics Q1 Earnings Miss Expectations

May 14 2026seekingalpha

Serina Unveils Novel POZ Platform Lipid Nanoparticles

Apr 07 2026Newsfilter

Serina Therapeutics Receives NYSE Compliance Plan Approval

Apr 06 2026NASDAQ.COM

Serina Therapeutics Receives NYSE Approval to Regain Listing Compliance

Apr 02 2026seekingalpha

Serina Therapeutics Reports FY Earnings and Secures Funding

Mar 26 2026seekingalpha

Serina Receives FDA Clearance for SER-252 Clinical Trial

Mar 25 2026Newsfilter

Serina Therapeutics Secures $30 Million Financing for Parkinson's Trial

Mar 19 2026NASDAQ.COM

Serina Therapeutics Secures Up to $30 Million for Parkinson's Treatment Development

Mar 18 2026seekingalpha

SER Events

Serina Therapeutics Files to Sell 16.45M Shares of Common Stock

Serina Therapeutics files to sell 16.45M shares of common stock for holders

Serina Therapeutics Appoints Greg Bailey as Co-Chairman of the Board

Serina Therapeutics announced Greg Bailey, a current board director, will assume the role of co-chairman of the board of directors. Greg Bailey will serve as co-chairman of the board of directors of Serina Therapeutics, alongside Simba Gill.

Serina Therapeutics Doses First Patient in SER-252 Parkinson's Trial

Serina Therapeutics announced that it has dosed the first patient in its Phase 1b registrational clinical trial evaluating SER-252 in patients with advanced Parkinson's disease.

SER Monitor News

Serina Therapeutics Secures $30 Million Financing for Parkinson's Trial

Serina Therapeutics Secures $30 Million Financing for Parkinson's Trial

Serina Therapeutics Secures $30 Million Financing for Parkinson's Trial

Serina Therapeutics Receives FDA Approval for SER-252

SER Earnings Analysis

No Data

No Data

People Also Watch